MIAMI--(BUSINESS WIRE)--Non-Invasive Monitoring Systems, Inc. [NIMS](OTCBB:NIMU) announced that the Canadian Patent Office issued Patent number 2,534,302 to NIMS on October 20, 2009. The patent, entitled “Reciprocating Movement Platform for the External Addition of Pulses to the Fluid Channels of a Subject”, relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform. The Canadian patent that expires August 4, 2024 incorporates 55 claims dealing with treatment of acute and chronic inflammatory diseases and is the Canadian counterpart to US Patent No. 7,404,221, the fifth patent issued for this technology.
